Information  X 
Enter a valid email address

Phorm Corporation (PHRM)


Monday 20 January, 2014

Phorm Corporation

Change of Adviser

RNS Number : 0028Y
Phorm Corporation Limited
20 January 2014

20 January 2014


Phorm Corporation Limited ("Phorm" or the "Company")


Change of Adviser

Phorm (AIM:PHRM), a leading internet personalisation technology company, is pleased to announce the appointment of Strand Hanson Limited as its Nominated Adviser with immediate effect.  Mirabaud Securities LLP has also assumed the role of sole Broker to the Company with immediate effect.


For further information please contact:


Phorm Corporation Limited

Andy Croxson (analysts and investors) +44 20 3397 6001


UK Investors

Mirabaud Securities LLP +44 20 7321 2508 (Broker)

Jason Woollard

Peter Krens


Strand Hanson Limited +44 20 7409 3494 (Nominated Adviser)

James Harris

Matthew Chandler

James Dance


US Investors

Lippert Heilshorn and Associates +1 212 838 3777 (Investor Relations)

John Heilshorn


About Phorm


Phorm is a global personalisation technology company that makes content and advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience.


Phorm's industry leading technology enables its ISP partners to offer a new type of online advertising platform and a free consumer internet content feature, ensuring more relevant advertisements and personalised content for opted-in users.


Phorm's advertising platform revolutionises current standards of online privacy, fully protecting the identity of consumers. Unlike virtually all other targeted advertising propositions, Phorm's solution is completely opt-in. Only those users consenting to the service are profiled and only ever on an anonymous basis.


Phorm's partners include leading Internet Service Providers (ISPs), Publishers, Advertising Networks and Advertisers.


Phorm, under a predecessor holding company, was admitted to the AIM market of the London Stock Exchange in 2004.


For more information, please visit:

This information is provided by RNS
The company news service from the London Stock Exchange

a d v e r t i s e m e n t